Leslie S. Bradford

Oncology
119 Belmont St
Worcester, MA 01605

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Paclitaxel Dosing Regimens Drive Differential CD4⁺ T Cell Responses in the Dorsal Root Ganglia and Modulate Neuropathic Pain Severity.

Paclitaxel Dosing Regimens Drive Differential CD4⁺ T Cell Responses in the Dorsal Root Ganglia and Modulate Neuropathic Pain Severity.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Journal: Gynecologic oncology
Published: March 04, 2026

Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute.

Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute.

Journal: Journal of Maine Medical Center
Published: February 05, 2026

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 20, 2024

Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.

Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.

Journal: JCO oncology practice
Published: May 22, 2024

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.

Journal: Journal of women's health (2002)
Published: March 15, 2024

The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study.

The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study.

Journal: Gynecologic oncology
Published: December 22, 2023

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).

Journal: NPJ precision oncology
Published: June 11, 2023

Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers.

Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers.

Journal: Menopause (New York, N.Y.)
Published: May 16, 2023

In Reply.

In Reply.

Journal: Obstetrics and gynecology
Published: April 20, 2021

A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant Approach.

A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant Approach.

Journal: Critical reviews in eukaryotic gene expression
Published: February 27, 2021

Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.

Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.

Journal: Journal of genetic counseling
Published: September 04, 2020
Showing 1-12 of 39

Last Updated: 09/26/2026